Evolus Inc

General ticker "EOLS" information:

  • Sector: Health Care
  • Industry: Pharmaceuticals
  • Capitalization: $776.8M

Evolus Inc follows the US Stock Market performance with the rate: 28.1%.

Estimated limits based on current volatility of 2.2%: low 10.65$, high 11.13$

Factors to consider:

  • Company does not operate outside North America (retrieved using AI)
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [5.37$, 11.72$]
  • 2024-12-30 to 2025-12-30 estimated range: [6.76$, 13.80$]

Financial Metrics affecting the EOLS estimates:

  • Negative: Non-GAAP EPS, $ of -0.72 <= 0.10
  • Negative: Operating profit margin, % of -19.93 <= 1.03
  • Negative: Operating cash flow per share per price, % of -5.75 <= 2.35
  • Negative: negative Net income

Similar symbols

Short-term EOLS quotes

Long-term EOLS plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $118.88MM $142.86MM $197.83MM
Operating Expenses $163.29MM $208.19MM $247.06MM
Operating Income $-44.41MM $-65.33MM $-49.23MM
Non-Operating Income $-2.36MM $-8.99MM $-12.28MM
Interest Expense $1.40MM $9.10MM $13.83MM
R&D Expense $2.06MM $4.74MM $6.56MM
Income(Loss) $-46.77MM $-74.32MM $-61.51MM
Taxes $0.04MM $0.10MM $0.18MM
Profit(Loss) $-46.81MM $-74.41MM $-61.69MM
Stockholders Equity $81.88MM $18.50MM $-20.69MM
Inventory $1.76MM $18.85MM $11.00MM
Assets $257.48MM $177.98MM $189.00MM
Operating Cash Flow $-33.39MM $-8.77MM $-34.01MM
Capital expenditure $0.97MM $2.94MM $1.63MM
Investing Cash Flow $4.03MM $-1.39MM $-1.63MM
Financing Cash Flow $73.05MM $-1.52MM $44.64MM
Earnings Per Share* $-0.94 $-1.33 $-1.08

* EPS are Split Adjusted, recent splits may be reflected with a delay.